Our study with stratification of testosterone levels has enhanced the association of variants of molecules in the EPHB6 signaling pathway with hypertension risks and revealed the association of a CHRNA3 variant with hypertension risks. The gene discussed is EPHB6; the disease is hypertensive disorder.